Article
Activation of JAK2-V617F by components of heterodimeric cytokine receptors.
The Journal of biological chemistry - 28 May 2010
Pradhan Anuradha, Lambert Que T, Griner Lori N, Reuther Gary W
Abstract excerpt
The JAK2-V617F mutation is an important etiologic factor for the development of myeloproliferative neoplasms. The mechanism by which this mutated tyrosine kinase initiates deregulated signals in cells is not completely understood. It is believed that JAK2-V617F requires interactions with homodimeric cytokine receptors to elicit its transforming signal. In this study, we demonstrate that components of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
